The ResMed Board of Directors announced a quarterly dividend of $0.42 per share. The last day to buy securities to receive the dividend is May 10, 2022. The annual dividend yield may reach 0.66%.

ResMed's GAAP net income for 9 months of fiscal 2022 was $584.4 million, up 2.1 times from $279.4 million in the prior year. Revenues increased 14.8% to $2.663 billion from $2.32 billion a year earlier.

ResMed's GAAP net income for 6 months of fiscal 2022 was $405.364 million, up 13.3% from $357.886 million in the prior year. Revenue increased 15.9% to $1.799 billion from $1.552 billion a year earlier.

ResMed's GAAP net income for 3M 2022 fiscal year was $203.613 million, up 14.2% from $178.372 million in the prior year. Revenue increased 20.2% to $904.015 million from $751.944 million a year earlier.